KPL-387
KPL-387-C211
Phase 3 small_molecule active
Quick answer
KPL-387 for Pericarditis is a Phase 3 program (small_molecule) at Kiniksa Pharmaceuticals International, plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kiniksa Pharmaceuticals International, plc
- Indication
- Pericarditis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active